HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
KCTD1
potassium channel tetramerization domain containing 1
Chromosome 18 Β· 18q11.2
NCBI Gene: 284252Ensembl: ENSG00000134504.14HGNC: HGNC:18249UniProt: A0A2U3U043
45PubMed Papers
21Diseases
0Drugs
13Pathogenic Variants
FUNCTIONAL ROLE
Transcription Factor
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
transcription corepressor activityprotein bindingtranscription factor bindingidentical protein bindingscalp-ear-nipple syndromeneurodegenerative diseasealcohol drinkingexostosis
✦AI Summary

KCTD1 (potassium channel tetramerization domain containing 1) is a nuclear transcriptional repressor that plays critical roles in developmental signaling and cellular regulation 1. The protein contains an N-terminal BTB (broad-complex, tramtrack, and bric-a-brac) domain that mediates both transcriptional repression and homomeric protein-protein interactions 1. KCTD1 functions as a general regulator of multiple developmental pathways, strongly inhibiting Wnt, Hedgehog, and Notch signaling cascades 2. Additionally, it modulates G protein-coupled receptor signaling by increasing adenylyl cyclase type 5 (AC5) abundance, thereby enhancing neuronal cAMP signaling in response to dopamine 23. KCTD1 forms multimeric complexes with KCTD15 and can compensate for each other's loss 4. Disease-causing mutations in KCTD1 are associated with scalp-ear-nipple syndrome, causing aplasia cutis congenita, ectodermal abnormalities, and kidney fibrosis 4. The protein exhibits oncosuppressive properties in colorectal cancer, with its downregulation associated with increased cell motility, stemness, and Ξ²-catenin overexpression 5. KCTD1's structural analysis reveals an unexpected pentameric assembly with ion-binding properties that contribute to its transcription factor binding capabilities 6.

Sources cited
1
KCTD1 is a nuclear transcriptional repressor containing a BTB domain that mediates transcriptional repression and homomeric interactions
PMID: 18358072
2
KCTD1 inhibits Wnt, Hedgehog, and Notch pathways and modulates GPCR signaling by increasing AC5 abundance
PMID: 41086914
3
KCTD1 regulates striatal AC5 levels and dopaminergic signaling through N-linked glycosylation
PMID: 39413138
4
KCTD1 forms complexes with KCTD15 and mutations cause aplasia cutis congenita and other developmental abnormalities
PMID: 38113115
5
KCTD1 has oncosuppressive properties in colorectal cancer, with downregulation associated with increased motility and Ξ²-catenin overexpression
PMID: 36979172
6
KCTD1 has a pentameric structure with ion-binding properties that contribute to TFAP2A binding
PMID: 39191250
Disease Associationsβ“˜21
scalp-ear-nipple syndromeOpen Targets
0.79Strong
neurodegenerative diseaseOpen Targets
0.52Moderate
alcohol drinkingOpen Targets
0.39Weak
exostosisOpen Targets
0.32Weak
luminal A breast carcinomaOpen Targets
0.30Weak
cholelithiasisOpen Targets
0.30Weak
breast cancerOpen Targets
0.30Weak
breast neoplasmOpen Targets
0.30Weak
ankylosing spondylitisOpen Targets
0.30Weak
estrogen-receptor positive breast cancerOpen Targets
0.29Weak
blood vessel replacementOpen Targets
0.28Weak
bronchial diseaseOpen Targets
0.25Weak
sudden cardiac arrestOpen Targets
0.22Weak
vascular diseaseOpen Targets
0.10Weak
hepatocellular carcinomaOpen Targets
0.08Suggestive
acute lymphoblastic leukemiaOpen Targets
0.07Suggestive
neoplasmOpen Targets
0.06Suggestive
familial juvenile hyperuricemic nephropathy type 1Open Targets
0.06Suggestive
Dent diseaseOpen Targets
0.06Suggestive
Hyperuricemia - anemia - renal failureOpen Targets
0.06Suggestive
Scalp-ear-nipple syndromeUniProt
Pathogenic Variants13
NM_001142730.3(KCTD1):c.2020A>T (p.Ile674Phe)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 674
NM_001142730.3(KCTD1):c.2056G>C (p.Asp686His)Likely pathogenic
Scalp-ear-nipple syndrome
β˜…β˜†β˜†β˜†2023β†’ Residue 686
NM_001142730.3(KCTD1):c.2009G>A (p.Gly670Asp)Likely pathogenic
Scalp-ear-nipple syndrome
β˜…β˜†β˜†β˜†2019β†’ Residue 670
NM_001142730.3(KCTD1):c.1921C>T (p.His641Tyr)Pathogenic
not provided
β˜…β˜†β˜†β˜†2016β†’ Residue 641
NM_001142730.3(KCTD1):c.1916C>G (p.Pro639Arg)Pathogenic
Scalp-ear-nipple syndrome
β˜†β˜†β˜†β˜†2014β†’ Residue 639
NM_001142730.3(KCTD1):c.1916C>T (p.Pro639Leu)Pathogenic
Scalp-ear-nipple syndrome
β˜†β˜†β˜†β˜†2014β†’ Residue 639
NM_001142730.3(KCTD1):c.1916C>A (p.Pro639His)Pathogenic
Scalp-ear-nipple syndrome
β˜†β˜†β˜†β˜†2014β†’ Residue 639
NM_001142730.3(KCTD1):c.1923C>A (p.His641Gln)Pathogenic
Scalp-ear-nipple syndrome
β˜†β˜†β˜†β˜†2014β†’ Residue 641
NM_001142730.3(KCTD1):c.1922A>C (p.His641Pro)Pathogenic
Scalp-ear-nipple syndrome
β˜†β˜†β˜†β˜†2014β†’ Residue 641
NM_001142730.3(KCTD1):c.2045A>C (p.His682Pro)Pathogenic
Scalp-ear-nipple syndrome
β˜†β˜†β˜†β˜†2014β†’ Residue 682
NM_001142730.3(KCTD1):c.2031C>A (p.Asp677Glu)Pathogenic
Scalp-ear-nipple syndrome
β˜†β˜†β˜†β˜†2014β†’ Residue 677
NM_001142730.3(KCTD1):c.1882C>T (p.Pro628Ser)Pathogenic
Scalp-ear-nipple syndrome
β˜†β˜†β˜†β˜†2014β†’ Residue 628
NM_001142730.3(KCTD1):c.1913C>A (p.Ala638Glu)Pathogenic
Scalp-ear-nipple syndrome
β˜†β˜†β˜†β˜†2014β†’ Residue 638
View on ClinVar β†—
Related Genes
TFAP2AProtein interaction94%TFAP2CProtein interaction94%TFAP2BProtein interaction93%UBE2IProtein interaction88%KCTD2Protein interaction81%KCTD6Shared pathway40%
Tissue Expression6 tissues
Brain
100%
Heart
49%
Ovary
43%
Liver
14%
Lung
12%
Bone Marrow
5%
Gene Interaction Network
Click a node to explore
KCTD1TFAP2ATFAP2CTFAP2BUBE2IKCTD2KCTD6
PROTEIN STRUCTURE
Preparing viewer…
PDB5BXD Β· 1.80 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.61LoF Tolerant
pLIβ“˜
0.09Tolerant
Observed/Expected LoF0.43 [0.31–0.61]
RankingsWhere KCTD1 stands among ~20K protein-coding genes
  • #9,471of 20,598
    Most Researched45
  • #2,620of 5,498
    Most Pathogenic Variants13
  • #4,194of 17,882
    Most Constrained (LOEUF)0.61 Β· top quartile
Genes detectedKCTD1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Characterization and expression of a human KCTD1 gene containing the BTB domain, which mediates transcriptional repression and homomeric interactions.
PMID: 18358072
DNA Cell Biol Β· 2008
1.00
2
Pathogenic variants in KCTD1 disrupt cAMP signaling and cellular communication associated with developmental pathways.
PMID: 41086914
J Biol Chem Β· 2025
0.90
3
Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1/HIF-1Ξ±/VEGF pathway.
PMID: 40227531
Cell Oncol (Dordr) Β· 2025
0.80
4
KCTD1/KCTD15 complexes control ectodermal and neural crest cell functions, and their impairment causes aplasia cutis.
PMID: 38113115
J Clin Invest Β· 2023
0.70
5
KCTD1 regulation of Adenylyl cyclase type 5 adjusts striatal cAMP signaling.
PMID: 39413138
Proc Natl Acad Sci U S A Β· 2024
0.60